{"organizations": [], "uuid": "b901ac0ff6835da2105cbe73db40c81c9b45b706", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180326.html", "section_title": "Archive News &amp; Video for Monday, 26 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-hybrigenics-broad-spectrum-inhibit/brief-hybrigenics-broad-spectrum-inhibitor-of-ubiquitin-specific-proteases-shows-antiviral-activity-against-human-adenoviruses-idUSFWN1R810G", "country": "US", "domain_rank": 408, "title": "BRIEF-Hybrigenics: Broad-Spectrum Inhibitor Of Ubiquitin-Specific Proteases Shows Antiviral Activity Against Human Adenoviruses", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.266, "site_type": "news", "published": "2018-03-27T00:57:00.000+03:00", "replies_count": 0, "uuid": "b901ac0ff6835da2105cbe73db40c81c9b45b706"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-hybrigenics-broad-spectrum-inhibit/brief-hybrigenics-broad-spectrum-inhibitor-of-ubiquitin-specific-proteases-shows-antiviral-activity-against-human-adenoviruses-idUSFWN1R810G", "ord_in_thread": 0, "title": "BRIEF-Hybrigenics: Broad-Spectrum Inhibitor Of Ubiquitin-Specific Proteases Shows Antiviral Activity Against Human Adenoviruses", "locations": [], "entities": {"persons": [{"name": "hybrigenics", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 26 (Reuters) - HYBRIGENICS SA:\n* BROAD-SPECTRUM INHIBITOR OF UBIQUITIN-SPECIFIC PROTEASES SHOWS ANTIVIRAL ACTIVITY AGAINST HUMAN ADENOVIRUSES\n* ON 11 OUT OF 13 VIRAL TYPES TESTED, HBX 47,939 WAS SHOWN TO INHIBIT VIRAL REPLICATION IN INFECTED CELLS\n* HBX 47,939 WAS SHOWN TO DECREASE PRODUCTION OF NEW VIRIONS RELEASED IN CULTURE MEDIUM Source text: bit.ly/2ITlGJG Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["https://bit.ly/2ITlGJG", "https://www.youtube.com/user/ReutersVideo", "https://twitter.com/reuters", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-03-27T00:57:00.000+03:00", "crawled": "2018-03-27T11:44:16.010+03:00", "highlightTitle": ""}